SE448344B - Antikropp for behandling av reumatoid artrit samt sett att framstella denna - Google Patents

Antikropp for behandling av reumatoid artrit samt sett att framstella denna

Info

Publication number
SE448344B
SE448344B SE7900798A SE7900798A SE448344B SE 448344 B SE448344 B SE 448344B SE 7900798 A SE7900798 A SE 7900798A SE 7900798 A SE7900798 A SE 7900798A SE 448344 B SE448344 B SE 448344B
Authority
SE
Sweden
Prior art keywords
milk
antibody
bacteria
immune
bacterial
Prior art date
Application number
SE7900798A
Other languages
English (en)
Swedish (sv)
Other versions
SE7900798L (sv
Inventor
R J Stolle
L R Beck
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of SE7900798L publication Critical patent/SE7900798L/
Publication of SE448344B publication Critical patent/SE448344B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE7900798A 1978-02-06 1979-01-30 Antikropp for behandling av reumatoid artrit samt sett att framstella denna SE448344B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87514078A 1978-02-06 1978-02-06

Publications (2)

Publication Number Publication Date
SE7900798L SE7900798L (sv) 1979-08-07
SE448344B true SE448344B (sv) 1987-02-16

Family

ID=25365266

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7900798A SE448344B (sv) 1978-02-06 1979-01-30 Antikropp for behandling av reumatoid artrit samt sett att framstella denna

Country Status (10)

Country Link
JP (1) JPS54113425A (fr)
CH (1) CH651210A5 (fr)
DE (1) DE2904044C2 (fr)
DK (1) DK158138C (fr)
FR (1) FR2416015A1 (fr)
GB (1) GB2013691B (fr)
HK (1) HK30283A (fr)
IT (1) IT1116524B (fr)
NL (1) NL7900766A (fr)
SE (1) SE448344B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
USRE33565E (en) * 1978-02-06 1991-04-02 Stolle Research And Development Corporation Prevention and treatment of rheumatioid arthritis
ATE14269T1 (de) * 1981-02-26 1985-08-15 Unilever Nv Verfahren und vorrichtung zur rueckgewinnung von immunoglobulinen.
EP0064103B1 (fr) * 1981-04-28 1985-11-06 The Stolle Research And Development Corporation Procédé d'obtention d'un lait bovin anti-inflammatoire
JP2561234B2 (ja) * 1981-05-12 1996-12-04 スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション 抗炎症剤
JPS58154513A (ja) * 1982-03-09 1983-09-14 Sendai Biseibutsu Kenkyusho 予防及び治療薬
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
EP0127712B1 (fr) * 1983-06-07 1989-01-11 The Stolle Research And Development Corporation Déodorant contenant des anticorps bactériens
JPS6112629A (ja) * 1984-06-28 1986-01-21 Lion Corp 口腔内組成物
EP0300102B1 (fr) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Méthode d'obtention de facteurs immunorégulateurs par immunisation de mammifères
JP2664906B2 (ja) * 1987-08-13 1997-10-22 ストール・リサーチ・アンド・デイベロップメント・コーポレーション 改良された哺乳類の免疫法
EP1171161A1 (fr) * 1999-04-19 2002-01-16 Richard Weisbart Traitement de la polyarthrite rhumatoide de l'adulte par l'administration orale d'immunoglobuline humaine provenant d'un pool de donneurs et d'un antiacide
JP2004525077A (ja) * 2000-09-28 2004-08-19 リサーチ　コーポレイション　テクノロジーズ，インコーポレイテッド イムノグロブリンｇ強化血漿画分の経口投与による免疫媒介性疾病の治療
EP1357942A2 (fr) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Procedes et compositions destines au traitement de dysfonctions immunitaires
EP1357943A2 (fr) * 2001-01-30 2003-11-05 The Lauridsen Group Incorporated Procedes et compositions destines a moduler le systeme immunitaire des animaux
JP4960632B2 (ja) * 2006-01-10 2012-06-27 学校法人北里研究所 免疫ミルク組成物を有効成分とする単純ヘルペスウイルス感染症治療予防用組成物
JP5361132B2 (ja) * 2006-03-10 2013-12-04 国立大学法人信州大学 免疫グロブリンｇを含有する経口用免疫調節剤、その製造方法及び経口用免疫調節剤を配合してなる飲食品
JP2008179572A (ja) * 2007-01-25 2008-08-07 Shinshu Univ 免疫グロブリンＦｃフラグメントレセプタータンパク及び／又は免疫グロブリンＦｃフラグメントレセプター様タンパク産生抑制剤及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1155730A (en) * 1965-10-24 1969-06-18 Immune Milk Company Of America Method of Producing Antitoxins
DE1617769A1 (de) * 1967-06-10 1971-04-01 Rehm Eberhard Verfahren zur Gewinnung von spezifischen Antikoerper enthaltender Milch und daraus hergestellter Praeparate
JPS5136326A (ja) * 1974-09-24 1976-03-27 Komatsu Seiren Co Seikeigorufubooru
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS521014A (en) * 1975-06-17 1977-01-06 Stolle Res & Dev Pharmaceutically acceptable carrier containing milk immunoglobulin
JPS5381613A (en) * 1976-12-28 1978-07-19 Green Cross Corp:The Remedies for enteral infection diseases
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin

Also Published As

Publication number Publication date
IT7947888A0 (it) 1979-02-05
CH651210A5 (de) 1985-09-13
DK158138B (da) 1990-04-02
IT1116524B (it) 1986-02-10
JPS54113425A (en) 1979-09-05
DK158138C (da) 1990-08-27
DE2904044C2 (de) 1986-02-06
FR2416015B1 (fr) 1983-06-17
FR2416015A1 (fr) 1979-08-31
NL7900766A (nl) 1979-08-08
GB2013691A (en) 1979-08-15
SE7900798L (sv) 1979-08-07
JPH0160455B2 (fr) 1989-12-22
DE2904044A1 (de) 1979-08-30
GB2013691B (en) 1982-08-18
HK30283A (en) 1983-09-02
DK49479A (da) 1979-08-07

Similar Documents

Publication Publication Date Title
US4732757A (en) Prevention and treatment of rheumatoid arthritis
SE448344B (sv) Antikropp for behandling av reumatoid artrit samt sett att framstella denna
Liebhaber et al. Alterations of lymphocytes and of antibody content of human milk after processing
US20100268658A1 (en) Method for collecting, testing and distributing milk
US4324782A (en) Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US7914822B2 (en) Method of producing nutritional products from human milk tissue and compositions thereof
Elberg et al. A guide to the diagnosis, treatment and prevention of human brucellosis
Gabriel Michael et al. The antimicrobial activity of human colostral antibody in the newborn
KR20000048855A (ko) 닭의 난황 항체를 경구 투여하여 질병을 치료하는 방법
Tawfeek et al. Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial
Hammon Staphylococcus enterotoxin: an improved cat test, chemical and immunological studies
KR890004019B1 (ko) 요로 감염 치료용 백신의 제조방법
USRE33565E (en) Prevention and treatment of rheumatioid arthritis
Moodley et al. The operculum syndrome: an unusual complication of tuberculous meningitis
Henderson et al. Clinical problems: Subclinical Brucella infection in man
Newby et al. The immune response of the pig following oral immunisation with soluble protein
Dawson et al. Immunological and Blood Products: Pharmaceutical Monographs
Nickerson et al. Studies of immune and normal opsonins during experimental staphylococcal infection in rabbits
ROSEBURY The Aerobic Non-hemolytic Streptococci: a Critical Review of their Characteristics and Pathogenicity with Special Reference to the Human Mouth and to Subacute Bacterial Endocarditis
Jones et al. UDDER INFECTION WITH STREPTOCOCCI OF THE SCARLET FEVER TYPE: I. Spontaneous and Experimental Udder Infection.
Nathanson et al. Cyclophosphamide-induced immunosuppression demonstrated in Pasteurella multocida-vaccinated chickens
Kohler et al. Studies of Escherichia Coli in Gnotobiotic Pigs: II. The Immune Response
Eyre et al. PROPHYLACTIC VACCINATIONS: AGAINST CATARRHAL AFFECTIONS OF THE RESPIRATORY TRACT
Cooper et al. Immune responses of rats to live Vibrio cholerae: antibodies in serum and intestinal secretions
Cullor Safety and efficacy of gram-negative bacterial vaccines

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7900798-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7900798-5

Format of ref document f/p: F